Home › Opioid Overdose › NCT06774248
Expanding the Youth Opioid Recovery Support (YORS) Intervention for MOUD Adherence to Adolescents With OUD
Who can join
Ages 13 to 21 · All sexes
Full eligibility criteria
Inclusion Criteria for adolescent patients with OUD: 1. English speaking 2. Provision of signed and dated informed assent form (may be collected verbally over audio and/or video platform in the event of a remote enrollment) 3. Willing to have a legal, English-speaking guardian provide informed consent (may be collected verbally over audio and/or video platform in the event of a remote enrollment) 4. Stated willingness to comply with all study procedures and the YORS intervention 5. Age 13-21 (inclusive) 6. Documented diagnosis of opioid use disorder (OUD) 7. Presenting for an index episode of inpatient or outpatient treatment at Maryland Treatment Centers with at least one day of opioid use in the 30 days prior to enrollment 8. Considering treatment with XR-NTX, XR-BUP, or SL-BUP\* OR has begun SL-BUP maintenance treatment within the past two weeks 9. Willing to designate a parent, family member, or other person to be involved in their OUD treatment as a Treatment Significant Other 10. Access to a mobile phone Inclusion criteria for Treatment Significant Other (TS) participants 1. English speaking 2. Provision of signed and dated informed consent form (may be collected verbally over audio and/or video platform in the event of a remote enrollment) 3. Stated willingness to comply with all study procedures and the YORS intervention 4. Parent, legal guardian, or other treatment support person designated by an adolescent patient participant to be involved in their OUD treatment as a Treatment Significant Other 5. Age 18 years or older 6. Access to a mobile phone Exclusion Criteria for adolescent patients with OUD: 1. Psychiatric or medical instability that, in the opinion of the PI, would preclude participation in the trial (e.g., suicidality, psychosis, Sickle Cell disease with frequent crises) 2. Living situation that, in the opinion of the PI, would preclude participation in the trial (e.g., location greater than 75 miles from the treatment center, homelessness) Exclusion Criteria for Treatment Significant Other (TSO) Participants: 1\. Known to currently be sharing drugs with the adolescent participant
About the study
Despite rising rates of fatal opioid overdoses in the United States, adolescents with OUD are far less likely than adults to receive and be retained on medication for opioid use disorder (MOUD). The multicomponent Youth Opioid Recovery Support (YORS) intervention for young adults seeks to increase adherence to extended-release MOUD and reduce opioid relapse through family involvement, assertive outreach, low-barrier access to MOUD, and contingency management. By expanding investigations of the evidence based YORS intervention to adolescents, especially those on sublingual buprenorphine, this project will significantly contribute to our knowledge base of practical strategies to address the opioid crisis in youth.
What is being tested
- Youth Opioid Recovery Support (YORS) (behavioral)
Sponsor: Potomac Health Foundations · Participants: 80 · Started: Feb 1, 2025
Contact the study team
- Kevin Wenzel, PhD · Phone: 410-233-1400
- Marc Fishman, MD · Phone: 410-233-1400
Official record on ClinicalTrials.gov — NCT06774248
Locations in the U.S.
| Maryland | Maryland Treatment Centers, Baltimore |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.